Full Text
The Full Text of this article is available as a PDF (96.0 KB).
letter . 2003 Nov;62(11):1116. doi: 10.1136/ard.62.11.1116
Experience with infliximab (anti-TNFα monoclonal antibody) as monotherapy for giant cell arteritis
A Andonopoulos
1, N Meimaris
1, D Daoussis
1, A Bounas
1, G Giannopoulos
1
A Andonopoulos
1Department of Medicine, Division of Rheumatology, University of Patras School of Medicine, Patras, Greece. andandon@med.upatras.gr
Find articles by A Andonopoulos
N Meimaris
1Department of Medicine, Division of Rheumatology, University of Patras School of Medicine, Patras, Greece. andandon@med.upatras.gr
Find articles by N Meimaris
D Daoussis
1Department of Medicine, Division of Rheumatology, University of Patras School of Medicine, Patras, Greece. andandon@med.upatras.gr
Find articles by D Daoussis
A Bounas
1Department of Medicine, Division of Rheumatology, University of Patras School of Medicine, Patras, Greece. andandon@med.upatras.gr
Find articles by A Bounas
G Giannopoulos
1Department of Medicine, Division of Rheumatology, University of Patras School of Medicine, Patras, Greece. andandon@med.upatras.gr
Find articles by G Giannopoulos
1Department of Medicine, Division of Rheumatology, University of Patras School of Medicine, Patras, Greece. andandon@med.upatras.gr
PMCID: PMC1754369 PMID: 14583578